{alpha}6 integrin is not the obligatory cell receptor for bovine papillomavirus type 4

This corrigendum addresses an error in a previously published research article about bovine papillomavirus type 4 (BPV4) and its cellular receptor. The original article investigated whether α6 integrin functions as the obligatory cell receptor for BPV4 infection. The correction specifies that a particular text passage on page 330 should reference specific monoclonal antibodies (GoH3 and 439-9B) when discussing the viral receptor mechanisms. This type of corrigendum is typical in scientific publishing, ensuring that experimental details and antibody identifications are accurately documented for reproducibility. The monoclonal antibodies mentioned were likely used in immunological assays or cell-based experiments to test α6 integrin's role in viral entry. Accurate identification of antibodies is crucial for other researchers attempting to replicate the study or build upon its findings. While brief, this correction maintains the integrity of the scientific record by clarifying which specific reagents were employed in the original investigation of BPV4 receptor biology.

Key findings

• A correction clarifies that monoclonal antibodies GoH3 and 439-9B were used in studies of bovine papillomavirus type 4
• The research examined α6 integrin's role as a cellular receptor for BPV4
• Accurate antibody identification is essential for experimental reproducibility in virology research